Search

everythinglearnresearchcommunity

for

Search:↓

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Bimatoprost is a safe and effective treatment for making eyelashes longer, thicker, and darker.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Blocking JAK-STAT signaling can lead to hair growth.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

New drug shows promise for better hair growth in baldness treatment.

Different countries have regulations to ensure the safety of hair care products, with some recalling hair straighteners due to high formaldehyde.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Minoxidil effectively treats female pattern hair loss.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

As people get older, they have less active hair growth, but women have thicker hair than men and respond better to hair loss treatments.

Once-daily 5% minoxidil foam increases hair regrowth and density in women with hair loss, but not as effectively as twice-daily 2% minoxidil solution, though it's safer and more convenient.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.